VanEck Biotech ETF - USD Share Price

ETF

BBH

US92189F7261

Market Closed - Nasdaq Other stock markets 01:45:00 27/04/2024 am IST			5-day change	1st Jan Change
155.6 ^USD	+0.53%		+2.37%	-5.88%

2020	VanEck Vectors Biotech ETF Announces 2020 Annual Distribution, Payable on December 28, 20200.6	CI
2019	VanEck Vectors Biotech ETF Announces Preliminary Year End Estimated Distribution, Payable on December 30, 2019	CI

Chart VanEck Biotech ETF - USD

Duration

Period

Style

Dynamic Chart

Investment objective

VanEck Vectors® Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.

Composition of VanEck Biotech ETF - USD

Name	Price	Change	5d. change	1st Jan change	Weight
AMGEN INC.	270 USD	+0.22%	+0.39%	-6.26%	19.50%
VERTEX PHARMACEUTICALS INCORPORATED	397.5 USD	-0.06%	+0.81%	-2.31%	11.25%
GILEAD SCIENCES, INC.	65.42 USD	+0.23%	-2.01%	-19.24%	9.94%
REGENERON PHARMACEUTICALS, INC.	883.2 USD	-0.84%	-1.52%	+0.56%	8.97%
MODERNA, INC.	108 USD	+1.69%	+6.47%	+8.57%	5.32%
IQVIA HOLDINGS INC.	234.9 USD	+0.38%	+2.98%	+1.51%	4.71%
BIOGEN INC.	208.9 USD	+3.18%	+7.47%	-19.27%	4.58%
ICON PUBLIC LIMITED COMPANY	308.3 USD	+2.74%	+6.97%	+8.92%	4.00%
ILLUMINA, INC.	122.3 USD	+1.02%	+4.13%	-12.18%	3.79%

See all (23)

All the latest ETF news

US equity funds see 4th straight week of outflows amid rate cut reassessment	26/04	RE
Global equity funds face fourth week of outflows amid dampened Fed rate cut hopes	26/04	RE
Record $8.8 bln pulled from US sustainable funds in Q1	25/04	RE
US SEC expected to deny spot ether ETFs next month, industry sources say	25/04	RE
IShares Premium Money Market ETF Announces Final April 2024 Cash Distribution, Payable on April 30, 2024	25/04	CI
Hong Kong spot crypto ETFs to start trading next week	24/04	RE
IShares Public Limited Company - iShares MSCI Europe ex-UK GBP Hedged UCITS ETF Announces Interim Distribution for the Year 2024, Payable on 15 May 2024	24/04	CI
Franklin Templeton launches two ETFs	24/04	FI

More news

In partnership with

Quotes 5-day view

Date	Price	Change	Volume
26/24/26	155.6	+0.53%	6,398
25/24/25	154.8	-1.63%	53,720
24/24/24	157.3	+0.11%	6,140
23/24/23	157.2	+1.66%	6,412
22/24/22	154.6	+1.46%	3,558

Other stock markets

Delayed Quote Nasdaq

Last update April 27, 2024 at 01:45 am IST

More quotes

ETF Ratings

Description

	US92189F7261
Total Expense Ratio	0.35%
Asset Class	Equities
Sector	Biotechnology
Size	No restriction
Currency	USD
Provider	VanEck
Underlying	MVIS US Listed Biotech 25 Net Total Return Index - USD

Features and characteristics

Jurisdiction	United States
Fund Structure	Open-end Fund
Replication Method	Direct (Physical)
Replication Model	Full Replication
Date of creation	20/12/2011
Dividend Policy	Distribution
Geographical Focus	United States

Distribution

Retail investor

AuM evolution ( 28/03/2024 )

AuM (EUR)	419 M€
AuM 1M	424 M€
AuM 3 months	444 M€
AuM 6 months	427 M€
AuM 12 months	450 M€